235 related articles for article (PubMed ID: 9593272)
1. Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cells.
Herman P; Ferrant A; De Bruyère M; Straetmans N
Leukemia; 1998 May; 12(5):735-45. PubMed ID: 9593272
[TBL] [Abstract][Full Text] [Related]
2. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
[TBL] [Abstract][Full Text] [Related]
3. Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects.
Koller MR; Palsson MA; Manchel I; Palsson BO
Blood; 1995 Sep; 86(5):1784-93. PubMed ID: 7544642
[TBL] [Abstract][Full Text] [Related]
4. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.
Prosper F; Vanoverbeke K; Stroncek D; Verfaillie CM
Blood; 1997 Jun; 89(11):3991-7. PubMed ID: 9166837
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo culture of CD34+/Lin-/DR- cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay.
Miller JS; McCullar V; Verfaillie CM
Blood; 1998 Jun; 91(12):4516-22. PubMed ID: 9616147
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
7. Direct contact between CD34+lin- cells and stroma induces a soluble activity that specifically increases primitive hematopoietic cell production.
Koller MR; Oxender M; Jensen TC; Goltry KL; Smith AK
Exp Hematol; 1999 Apr; 27(4):734-41. PubMed ID: 10210331
[TBL] [Abstract][Full Text] [Related]
8. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
Verfaillie CM; Miller JS
Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
[TBL] [Abstract][Full Text] [Related]
9. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells.
Gupta P; McCarthy JB; Verfaillie CM
Blood; 1996 Apr; 87(8):3229-36. PubMed ID: 8605338
[TBL] [Abstract][Full Text] [Related]
10. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
Shaw PH; Olszewski M; Kletzel M
J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
12. Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells.
Möbest D; Mertelsmann R; Henschler R
Biotechnol Bioeng; 1998 Nov; 60(3):341-7. PubMed ID: 10099437
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells.
Halle P; Rouzier C; Kanold J; Boiret N; Rapatel C; Mareynat G; Tchirkov A; Berger M; Travade P; Bonhomme J; Deméocq F
Ann Hematol; 2000 Jan; 79(1):13-9. PubMed ID: 10663616
[TBL] [Abstract][Full Text] [Related]
14. Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro.
Srour EF; Brandt JE; Briddell RA; Grigsby S; Leemhuis T; Hoffman R
Blood; 1993 Feb; 81(3):661-9. PubMed ID: 7678996
[TBL] [Abstract][Full Text] [Related]
15. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation.
Piacibello W; Sanavio F; Garetto L; Severino A; Dané A; Gammaitoni L; Aglietta M
Leukemia; 1998 May; 12(5):718-27. PubMed ID: 9593270
[TBL] [Abstract][Full Text] [Related]
16. Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.
Litzow MR; Brashem-Stein C; Andrews RG; Bernstein ID
Blood; 1991 Jun; 77(11):2354-9. PubMed ID: 1710150
[TBL] [Abstract][Full Text] [Related]
17. Effect of interleukin-3, stem cell factor and granulocyte-macrophage colony-stimulating factor on committed stem cells, long-term culture initiating cells and bone marrow stroma in a one-step long-term bone marrow culture.
Keil F; Chen X; Louda N; Zsuh H; Schneider B; Lechner K; Kalhs P; Greinix HT
Ann Hematol; 2000 May; 79(5):243-8. PubMed ID: 10870478
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
[TBL] [Abstract][Full Text] [Related]
19. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
20. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins.
Gupta P; Oegema TR; Brazil JJ; Dudek AZ; Slungaard A; Verfaillie CM
Blood; 2000 Jan; 95(1):147-55. PubMed ID: 10607697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
